Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine for pain control during emergence from remifentanil anesthesia in laparoscopic cholecystectomy
ChiCTR2400083033Phase 4Recruiting
- Sponsor
- Dongguan Donghua Hospital
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in postoperative pain (2 arms), sponsored by Dongguan Donghua Hospital. Primary endpoint: Pain score during postoperative recovery. Started May 2024; status: recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400083033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083033.